お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:ネブライザー - 医療機器のパイプライン評価
市場調査レポート
商品コード
606449

ネブライザー - 医療機器のパイプライン評価

Nebulizers - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 119 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
ネブライザー - 医療機器のパイプライン評価
出版日: 2020年02月15日
発行: GlobalData
ページ情報: 英文 119 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、ネブライザーのパイプライン製品について調査し、製品開発・治験の全体的な進行状況や、企業・製品別の詳細動向、近年の開発・資本取引の動向などを包括的にまとめています。

第1章 目次

第2章 イントロダクション

  • ネブライザーの概要

第3章 開発中のパイプライン製品

  • ネブライザー:開発段階別
  • ネブライザー:セグメント別
  • ネブライザー:地域/国別
  • ネブライザー:承認機関別
  • ネブライザー:推定承認時期
  • ネブライザー:現在進行中の治験

第4章 開発中のパイプライン製品:企業別

  • ネブライザー製造企業:開発段階別のパイプライン製品
  • ネブライザー:開発段階別のパイプライン製品

第5章 ネブライザー:企業および製品概要

  • Ablynx NV
    • パイプライン製品と現在進行中の治験概要
  • Aeon Research & Technology
  • AerovectRx Corporation
  • AFT Pharmaceuticals Ltd
  • Aura Medical
  • Baby's Breath Ltd.
  • Creare Inc
  • DesignWise Medical Inc
  • Marquette University
  • Parion Sciences Inc
  • SolAeroMed Inc
  • Stirling Pharma Inc
  • University of California San Diego
  • University of Texas Medical Branch at Galveston
  • Verona Pharma Plc

第6章 ネブライザー市場 - 近年の動向

第7章 付録

  • 調査手法
  • GlobalDataについて
  • 連絡先
  • 免責事項

図表リスト

図表

List of Tables

  • Table 1: Nebulizers - Pipeline Products by Stage of Development
  • Table 2: Nebulizers - Pipeline Products by Segment
  • Table 3: Nebulizers - Pipeline Products by Territory
  • Table 4: Nebulizers - Pipeline Products by Regulatory Path
  • Table 5: Nebulizers - Pipeline Products by Estimated Approval Date
  • Table 6: Nebulizers - Ongoing Clinical Trials
  • Table 7: Nebulizers Companies - Pipeline Products by Stage of Development
  • Table 8: Nebulizers - Pipeline Products by Stage of Development
  • Table 9: Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Customised Infant Inhalation Device - Product Status
  • Table 11: Customised Infant Inhalation Device - Product Description
  • Table 12: Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: LYNX Nebulizer - Product Status
  • Table 14: LYNX Nebulizer - Product Description
  • Table 15: AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: NasoSURF - Product Status
  • Table 17: NasoSURF - Product Description
  • Table 18: AFT Pharmaceuticals Ltd - Ongoing Clinical Trials Overview
  • Table 19: NasoSURF - A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers
  • Table 20: Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Nebican - Product Status
  • Table 22: Nebican - Product Description
  • Table 23: Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: WiseAir - Product Status
  • Table 25: WiseAir - Product Description
  • Table 26: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: DDC-Based Nebulizer - Product Status
  • Table 28: DDC-Based Nebulizer - Product Description
  • Table 29: DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Self-Contained Nebulizer System - Product Status
  • Table 31: Self-Contained Nebulizer System - Product Description
  • Table 32: HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Deepro - Product Status
  • Table 34: Deepro - Product Description
  • Table 35: Marquette University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Human Powered Nebulizer - Product Status
  • Table 37: Human Powered Nebulizer - Product Description
  • Table 38: Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: tPAD Device - Product Status
  • Table 40: tPAD Device - Product Description
  • Table 41: SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: S1226 Neublizer System - Product Status
  • Table 43: S1226 Neublizer System - Product Description
  • Table 44: Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: High Density Aerosol Drug Delivery Device - Product Status
  • Table 46: High Density Aerosol Drug Delivery Device - Product Description
  • Table 47: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Nebulizer - Product Status
  • Table 49: Nebulizer - Product Description
  • Table 50: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Pulse Drug Nebulization System - Product Status
  • Table 52: Pulse Drug Nebulization System - Product Description
  • Table 53: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: RPL554 Nebulizer - Product Status
  • Table 55: RPL554 Nebulizer - Product Description
  • Table 56: Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Home Use Ultrasonic Nebulizer - Product Status
  • Table 58: Home Use Ultrasonic Nebulizer - Product Description
  • Table 59: Glossary

List of Figures

  • Figure 1: Nebulizers - Pipeline Products by Stage of Development
  • Figure 2: Nebulizers - Pipeline Products by Segment
  • Figure 3: Nebulizers - Pipeline Products by Territory
  • Figure 4: Nebulizers - Pipeline Products by Regulatory Path
  • Figure 5
目次
Product Code: GDME0905EPD

GlobalData's Medical Devices sector report, "Nebulizers - Medical Devices Pipeline Assessment, 2020" provides an overview of Nebulizers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Incontinence Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nebulizers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nebulizers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Nebulizers Overview

3 Products under Development

  • 3.1 Nebulizers - Pipeline Products by Stage of Development
  • 3.2 Nebulizers - Pipeline Products by Segment
  • 3.3 Nebulizers - Pipeline Products by Territory
  • 3.4 Nebulizers - Pipeline Products by Regulatory Path
  • 3.5 Nebulizers - Pipeline Products by Estimated Approval Date
  • 3.6 Nebulizers - Ongoing Clinical Trials

4 Nebulizers - Pipeline Products under Development by Companies

  • 4.1 Nebulizers Companies - Pipeline Products by Stage of Development
  • 4.2 Nebulizers - Pipeline Products by Stage of Development

5 Nebulizers Companies and Product Overview

  • 5.1 Ablynx NV Company Overview
  • 5.2 Aeon Research & Technology Company Overview
  • 5.3 AFT Pharmaceuticals Ltd Company Overview
  • 5.4 Aura Medical Company Overview
  • 5.5 Baby's Breath Ltd. Company Overview
  • 5.6 Creare LLC Company Overview
  • 5.7 DesignWise Medical Inc (Inactive) Company Overview
  • 5.8 HCmed Innovations Co Ltd Company Overview
  • 5.9 Marquette University Company Overview
  • 5.10 Parion Sciences Inc Company Overview
  • 5.11 SolAeroMed Inc Company Overview
  • 5.12 Stirling Pharma Inc Company Overview
  • 5.13 University of California San Diego Company Overview
  • 5.14 University of Texas Medical Branch at Galveston Company Overview
  • 5.15 Verona Pharma Plc Company Overview
  • 5.16 Vincent Medical Holdings Ltd Company Overview

6 Nebulizers- Recent Developments

  • 6.1 Nov 12, 2019: Monaghan Medical wins prestigious Zenith Award from the American Association of Respiratory Care
  • 6.2 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020
  • 6.3 Nov 06, 2019: Owens & Minor reports 3rd quarter 2019 financial results
  • 6.4 Nov 06, 2019: Owens & Minor announces new organizational structure to better serve customers
  • 6.5 Oct 31, 2019: Teleflex reports third quarter 2019 results
  • 6.6 Oct 30, 2019: United Therapeutics reports third quarter 2019 financial results
  • 6.7 Oct 29, 2019: Vectura Group appoints New Chief Executive Officer
  • 6.8 Oct 22, 2019: HCmed introduces Pulmogine in the 2019 ERS Congress
  • 6.9 Oct 16, 2019: Boehringer Ingelheim announces first patient enrolled in phase II trial of novel Cystic Fibrosis treatment (BALANCE-CF 1)
  • 6.10 Oct 01, 2019: New data reinforces benefits of Spiolto Respimat in improving patient outcomes

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.